UBS Group AG - CAN-FITE BIOPHARMA LTD ownership

CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 12 filers reported holding CAN-FITE BIOPHARMA LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CAN-FITE BIOPHARMA LTD
ValueSharesWeighting
Q4 2018$2,0000.0%1,547
+12.3%
0.00%
Q3 2018$2,000
-33.3%
1,378
-48.6%
0.00%
Q2 2018$3,000
+200.0%
2,683
+607.9%
0.00%
Q4 2017$1,000
-50.0%
379
-71.2%
0.00%
Q3 2017$2,000
-66.7%
1,314
-45.8%
0.00%
Q4 2016$6,000
+500.0%
2,425
+1088.7%
0.00%
Q3 2016$1,000
-93.8%
204
-96.6%
0.00%
Q2 2016$16,000
+45.5%
6,080
+17.1%
0.00%
Q2 2015$11,000
+120.0%
5,194
+129.7%
0.00%
Q1 2015$5,000
+400.0%
2,261
+484.2%
0.00%
Q4 2014$1,0003870.00%
Other shareholders
CAN-FITE BIOPHARMA LTD shareholders Q1 2015
NameSharesValueWeighting ↓
TAYLOR ASSET MANAGEMENT INC 348,500$763,0000.14%
MENTA CAPITAL LLC 12,200$27,0000.00%
Virtu KCG Holdings LLC 22,042$48,0000.00%
MSI Financial Services Inc 2,000$4,0000.00%
Tower Research Capital LLC (TRC) 458$1,0000.00%
UBS Group AG 5,194$11,0000.00%
CITIGROUP INC 17$00.00%
View complete list of CAN-FITE BIOPHARMA LTD shareholders